BioInvent International AB (publ) (STO:BINV)
Sweden
· Delayed Price · Currency is SEK 29.40
+0.35 (1.20%)
Mar 28, 2025, 1:37 PM CET
STO:BINV Revenue
In the year 2024, BioInvent International AB had annual revenue of 44.69M SEK, down -37.47%. BioInvent International AB had revenue of 21.37M in the quarter ending December 31, 2024, with 39.49% growth.
Revenue
44.69M
Revenue Growth
-37.47%
P/S Ratio
43.33
Revenue / Employee
391.98K
Employees
114
Market Cap
1.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.69M | -26.78M | -37.47% |
| Dec 31, 2023 | 71.46M | -254.67M | -78.09% |
| Dec 31, 2022 | 326.13M | 306.74M | 1,582.45% |
| Dec 31, 2021 | 19.38M | -127.99M | -86.85% |
| Dec 31, 2020 | 147.37M | 53.63M | 57.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBioInvent International AB News
- 6 months ago - Transgene and BioInvent's Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments - Benzinga